chlorambucil has been researched along with Angiofollicular Lymph Hyperplasia in 4 studies
Chlorambucil: A nitrogen mustard alkylating agent used as antineoplastic for chronic lymphocytic leukemia, Hodgkin's disease, and others. Although it is less toxic than most other nitrogen mustards, it has been listed as a known carcinogen in the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (Merck Index, 11th ed)
chlorambucil : A monocarboxylic acid that is butanoic acid substituted at position 4 by a 4-[bis(2-chloroethyl)amino]phenyl group. A chemotherapy drug that can be used in combination with the antibody obinutuzumab for the treatment of chronic lymphocytic leukemia.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Castleman disease is a rare cause of lymphoid hyperplasia and may result in localized symptoms or an aggressive, multisystem disorder." | 1.48 | Sjögren's and plasma cell variant Castleman disease: a case report. ( Abrahams, AD; Dei-Adomakoh, YA; Dey, DI; Quarcoopome, L; Segbefia, CI, 2018) |
| "Multicentric Castleman's disease (MCD), or multicentric angiofollicular lymph node hyperplasia, is an uncommon lymphoproliferative disorder which typically present with constitutional symptoms, multicentric lymphadenopathy, hepatosplenomegaly, effusions, and ascites." | 1.29 | Presentation of multicentric Castleman's disease with sicca syndrome, cardiomyopathy, palmar and plantar rash. ( Cripe, LD; Hall, BD; Kingsmore, SF; Sheldon, EA; Silva, OE; St Clair, EW, 1993) |
| "A case of angiofollicular lymph node hyperplasia of plasma cell type in a 60-year-old woman is reported." | 1.28 | A successfully treated case of multicentric angiofollicular hyperplasia with oral chemotherapy (Castleman's disease). ( Bai, MC; Bourantas, CL; Pavlidis, NA; Skopouli, FN, 1990) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dei-Adomakoh, YA | 1 |
| Quarcoopome, L | 1 |
| Abrahams, AD | 1 |
| Segbefia, CI | 1 |
| Dey, DI | 1 |
| Senanayake, S | 1 |
| Kelly, J | 1 |
| Lloyd, A | 1 |
| Waliuzzaman, Z | 1 |
| Goldstein, D | 1 |
| Rawlinson, W | 1 |
| Kingsmore, SF | 1 |
| Silva, OE | 1 |
| Hall, BD | 1 |
| Sheldon, EA | 1 |
| Cripe, LD | 1 |
| St Clair, EW | 1 |
| Pavlidis, NA | 1 |
| Skopouli, FN | 1 |
| Bai, MC | 1 |
| Bourantas, CL | 1 |
4 other studies available for chlorambucil and Angiofollicular Lymph Hyperplasia
| Article | Year |
|---|---|
Sjögren's and plasma cell variant Castleman disease: a case report.
Topics: Adult; Anemia, Hemolytic; Castleman Disease; Chlorambucil; Diagnosis, Differential; Drug Therapy, Co | 2018 |
Multicentric Castleman's disease treated with antivirals and immunosuppressants.
Topics: Aged; Anti-Inflammatory Agents; Antineoplastic Agents, Alkylating; Antiviral Agents; Castleman Disea | 2003 |
Presentation of multicentric Castleman's disease with sicca syndrome, cardiomyopathy, palmar and plantar rash.
Topics: Adult; Cardiomyopathies; Castleman Disease; Chlorambucil; Female; Foot; Hand; Humans; Prednisone; Sj | 1993 |
A successfully treated case of multicentric angiofollicular hyperplasia with oral chemotherapy (Castleman's disease).
Topics: Antineoplastic Combined Chemotherapy Protocols; Castleman Disease; Chlorambucil; Female; Humans; Mid | 1990 |